作为治疗点的TREM-1和TREM-2:临床挑战和前景
1SignaBlok, Inc., Shrewsbury, MA, United States.
Frontiers in immunology
|December 31, 2024
概括
在骨髓细胞-1 (TREM-1) 和TREM-2上表达的触发受体作为潜在的治疗点被探索. 本综述讨论了在疾病治疗中利用这些受体的临床挑战和未来前景.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在髓状细胞 (TREM) 蛋白中表达的触发受体,TREM-1和TREM-2,在调节免疫反应中起着至关重要的作用.
- TREM-1和TREM-2通路的失调与各种炎症和自身免疫性疾病有关.
- 了解TREM-1和TREM-2的特定功能对于开发向疗法至关重要.
研究的目的:
- 审查当前对TREM-1和TREM-2作为治疗点的理解.
- 确定与向这些受体相关的临床挑战.
- 为基于TREM-1和TREM-2的治疗方法的未来发展提供视角.
主要方法:
- 文献综述和有关TREM-1和TREM-2现有研究的综合.
- 分析与TREM-1和TREM-2调制相关的临床前和临床数据.
- 讨论潜在的治疗策略及其相关障碍.
主要成果:
- TREM-1通常与促炎反应有关,而TREM-2通常与抗炎和平静功能有关.
- 向TREM-1可能在炎症状况中提供好处,但可能会加剧某些免疫抑制的风险.
- 在神经退行性疾病和组织修复方面,TREM-2调节显示出有前途,但需要精确控制以避免意外后果.
结论:
- TREM-1和TREM-2代表了有希望的,但复杂的治疗点.
- 克服特异性,输送和潜在副作用方面的挑战对于临床翻译至关重要.
- 对TREM-1和TREM-2复杂作用的进一步研究将为新型免疫调节治疗铺平道路.
相关概念视频
Enzyme-linked Receptors
77.2K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.2K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


